The aim of the present study was to investigate the effectiveness of tizanidine hydrochloride (Sirdalud®, Novartis Pharma) in the treatment of myofascial pain of the masticatory muscles, by means of a randomized, double blind, placebo controlled clinical trial.
Efficacy of tizanidine hydrochloride in the treatment of myofascial pain of the masticatory muscles. A randomized controlled clinical trial / Manfredini, D; Segu', M; Orlando, B; Bosco, M. - (2005). (Intervento presentato al convegno 4th International Conference of Orofacial Pain and Temporomandibular Disorders (ICOT 2005). tenutosi a Sydney Convention and Exhibition Centre Darling Harbour, Sydney, Australia nel 26-28 August 2005).
Efficacy of tizanidine hydrochloride in the treatment of myofascial pain of the masticatory muscles. A randomized controlled clinical trial
SEGU' M;
2005-01-01
Abstract
The aim of the present study was to investigate the effectiveness of tizanidine hydrochloride (Sirdalud®, Novartis Pharma) in the treatment of myofascial pain of the masticatory muscles, by means of a randomized, double blind, placebo controlled clinical trial.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
